AbbVie Inc.
NYSE:ABBV
Overview | Financials
Company Name | AbbVie Inc. |
Symbol | ABBV |
Currency | USD |
Price | 203.55 |
Market Cap | 359,538,507,000 |
Dividend Yield | 3.75% |
52-week-range | 135.85 - 207.32 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Richard A. Gonzalez |
Website | https://www.abbvie.com |
An error occurred while fetching data.
About AbbVie Inc.
AbbVie Inc. is a global pharmaceutical company focused on discovering, developing, manufacturing, and selling innovative therapies. Their diverse portfolio offers treatments for various medical conditions.
Notable products include HUMIRA, used for autoimmune and intestinal Behçet's diseases, and SKYRIZI, for moderate to severe plaque psoriasis in adults. They also offer RINVOQ for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD